Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,808.12
-1.74(-0.03%)
Dow 30
42,114.40
-259.96(-0.61%)
Nasdaq
18,518.61
+103.12(+0.56%)
Russell 2000
2,207.99
-10.93(-0.49%)
Crude Oil
71.69
+1.50(+2.14%)
Gold
2,760.80
+11.90(+0.43%)

Penumbra, Inc. (PEN)

NYSE - Nasdaq Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

204.71

-1.84

(-0.89%)

At close: 04:00PM EDT

204.71

0.00

(0.00%)

After hours:

06:21PM EDT

Trade prices are not sourced from all markets

Previous Close	206.55
Open	206.00
Bid	205.91 x 900
Ask	206.49 x 900
Day's Range	203.72 - 206.72
52 Week Range	148.00 - 277.34
Volume	244,602
Avg. Volume	445,595

Market Cap	7.952B
Beta (5Y Monthly)	0.55
PE Ratio (TTM)	584.89
EPS (TTM)	0.35
Earnings Date	Oct 30, 2024
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	217.81

All

Zacks
Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Penumbra (PEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Dominion Energy (D) Reports Next Week: Wall Street Expects Earnings Growth
  Zacks
- Waters (WAT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
  Zacks
Medical Device Network
Penumbra completes enrolment for THUNDER study to treat ischemic stroke
The single-arm, multicentre trial targets patients with acute ischemic stroke caused by intracranial LVO.